Environment
Mixed / Neutral
50%
Benefits
- No direct sector effect identified.
Risks
- No direct sector effect identified.
StateNew JerseyIntroduced
A 4852: Revises certain requirements for prescription of Schedule II controlled dangerous substances via telemedicine and telehealth without in-person examination or review.*
Andrea Katz
A 4852 status: Introduced — Approved P.L.2026, c.40 (updated Jul 8, 2026).
Source
LegiScan
Confidence
High
Analysis basis
LegiScan full bill text
01
What this bill does
Official summary alongside an AI-generated read on where it stands and why.
Overall Score
75OUT OF 100
Score:75/100 civic fit
Risk:Moderate Risk
Impact:Moderate Impact 60/100
Earlier scoring method. Reanalyze to use the sector calculation.
Constitutionality100%
Bipartisan90%
Public opinion85%
Bill summary
The bill shifts regulatory requirements for the prescription of high-risk controlled substances via telehealth, affecting clinical practice standards and patient access across New Jersey.
02
Impact analysis
✦ AI analysisModeled effects across six domains, estimated from bill text and comparable legislation.
Economy
Positive outlook
65%
Benefits
- Increases market efficiency for telehealth providers.
- Reduces travel costs for patients in remote areas.
Risks
- Imposes administrative burden on providers to ensure compliance.
- Potentially increases costs for monitoring and regulatory oversight.
Society
Positive outlook
75%
Benefits
- Expands access for patients with chronic conditions.
- Allows flexibility for vulnerable populations like hospice patients.
Risks
- Potential for misuse of addictive Schedule II substances.
- Clinical limitations of remote assessment for complex psychiatric stimulant management.
Technology Industry
Not scored in this analysis.
Generate analysis again to evaluate this sector.
Civic Accountability
Not scored in this analysis.
Generate analysis again to evaluate this sector.
Public Health & Safety
Not scored in this analysis.
Generate analysis again to evaluate this sector.
03
How trustworthy & consequential it is
Sourcing already shown above, this is what the analysis found worth flagging.
Source
LegiScan
Official bill text or data from LegiScan.
Confidence
High
Information is complete and verified.
Analysis basis
LegiScan full bill text
Source used for this bill's analysis.
Source note
Relaxing in-person examination requirements for Schedule II substances carries inherent risks of diversion and misuse.
Analysis scope
Analysis relies exclusively on the provided text of A 4852.
04
Where it stands
Official record- IntroducedCurrent
- CommitteeUpcoming
- Chamber votesUpcoming
- Final agreementUpcoming
- GovernorUpcoming
- EnactedUpcoming
05
How it affects your district
✦ Personalized
Set your location
Add your district to see how this bill may affect your community and who to contact.
Your Representatives
Your representatives appear here once you add your location.
06
Take action
Contact your representatives
Let them know how you feel about this bill.
Share your view
Join the discussion and see what others are saying.
Track this bill
Stay updated on progress and changes.